Anixa Biosciences Inc — Director's Dealing 2013

Jul 16, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2013-07-15

Reporting Person: HERMS HENRY P (Director, VP Finance and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-15	Common Stock	M	280000	$0.16	Acquired	570575	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-15	Common Stock Purchase Warrants (Right to Buy)	$0.16	M	280000	Disposed	2016-02-08	Common Stock (280000)	Direct

Footnotes

F1: The exercise price was reduced from $0.1786 to $0.16 for warrants exercised during the period from June 1, 2013 to July 15, 2013.

F2: On February 8, 2011, Mr. Herms purchased 280,000 shares of Common Stock and 280,000 warrants to purchase Common Stock for an aggregate purchase price of $50,000 from the Company in a private placement.